Targeting RNA 2019
13-11-2019 10:00 - 17:00
Tuborg Havnevej 19
2900 - Hellerup
Novo Seeds, BioInnovation Institute and NovoNordisk Fonden and the Danish RNA Society
The scientific networking event will bring together entrepreneurial scientists with speakers and funding bodies, all with the aim to stimulate translation and commercialization of RNAbased
research projects. RNA has seen a number of successes in the pharmaceutical and biotech sector over the past years with the approval of Spinraza (nusinersen) and Onpattro (patisiran) and the
progression of high-profile biotech companies like Moderna, Curevac and Biontech. Denmark has a high reputation when it comes to RNA given the success story of Santaris
and its acquisition by Roche.
The program will consists of a variety of topics and scientists are urged to submit an abstract on translational projects through the registration process.
Register through the link on this page. Deadline for registering is October 31. Limited number of tickets. There will be a waiting list.
Call for abstracts
Scientists are encouraged to submit an abstract discussing their translational RNA project. The abstract should discuss the technology, application and corresponding unmet need and can't exceed one page. Deadline for submission is October 31.
10:00 - 10:30 – Registration and coffee
10:30 - 10:45 – Welcome by Jan Gorodkin and Jeroen Bakker
10:45 - 11:30 – Introduction to NNF, BII and Novo Seeds
11:30 - 12:00 – Keynote by Henrik Ørum: “Taking RNA from bench to bedside, an entrepreneur’s perspective”
12:00 - 13:00 – Lunch and networking
13:00 - 14:00 – Keynote by Janusz Bujnicki: "Computational modeling of RNA interactions with small molecules: RNA-ligand docking and beyond"
14:00 - 14:30 - Panel discussion on translation of RNA research: Jeroen Bakker, Janusz Bujnicki, Jørgen Kjems
14:30 - 15:00 - Coffee break
15:00 - 17:00 – Presentation of selected abstracts (15 min/project)